Here, we show that in both COVID-19–recovered and –naive individuals, BNT162b2 mRNA vaccination induces robust SARS-CoV-2–specific neutralizing antibodies, ADCC-mediating antibodies, and CD4+ and CD8+ T cells. Here, CD4 is linked to COVID-19.